What is the maximum dose of gabapentin (Neurontin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2025 • View editorial policy

From the Guidelines

The maximum recommended dose of gabapentin for adults is typically 3,600 mg per day, divided into three equal doses. This means taking 1,200 mg three times daily 1, 2. However, dosing should be individualized based on the condition being treated and patient response. For patients with renal impairment, the maximum dose needs to be reduced according to creatinine clearance.

Important Considerations

  • Gabapentin works by binding to calcium channels in the nervous system, reducing the release of excitatory neurotransmitters that contribute to seizures and pain.
  • The medication is usually started at a lower dose (such as 300 mg on day 1, 300 mg twice daily on day 2, and 300 mg three times daily on day 3) and gradually increased to minimize side effects like dizziness and somnolence 2.
  • Common side effects include drowsiness, dizziness, peripheral edema, and ataxia.
  • Patients should not abruptly discontinue gabapentin as this may precipitate seizures; instead, the medication should be tapered gradually over at least one week when discontinuation is necessary.

Key Points to Remember

  • The maximum dose of gabapentin can be increased until pain relief, dose-limiting adverse effects, or 3600 mg/d in 3 divided doses is reached 1.
  • An adequate trial of treatment with gabapentin can require 2 months or more 1.
  • Dose adjustment is required for patients with renal insufficiency 2.

From the FDA Drug Label

Dosages up to 2400 mg/day have been well tolerated in long-term clinical studies Doses of 3600 mg/day have also been administered to a small number of patients for a relatively short duration, and have been well tolerated.

  • The maximum dose of gabapentin that has been administered and well-tolerated is 3600 mg/day.
  • However, the recommended maintenance dose is between 300 mg to 600 mg three times a day (1800 mg/day) for postherpetic neuralgia and 300 mg to 600 mg three times a day for epilepsy with partial onset seizures.
  • It is essential to note that doses greater than 1800 mg/day did not demonstrate additional benefit in clinical studies 3.

From the Research

Maximum Dose of Gabapentin

The maximum dose of gabapentin varies depending on the condition being treated and the individual patient's response.

  • For adults with epilepsy, gabapentin may be initiated at a dosage of 900 mg/d and titrated to maintenance dosages of ≥ 3600 mg/d 4.
  • For adults with neuropathic pain, doses up to 3600 mg/d may be needed for greater efficacy 5, 6.
  • The effective dose should be individualized according to patient response and tolerability 6.

Key Findings

  • Gabapentin is considered a safe and well-tolerated antiepileptic drug with a favorable pharmacokinetic profile and a broad therapeutic index 4.
  • High doses of gabapentin (≥ 3600 mg/d) may be tolerated well by most patients without an increase in adverse reactions 4, 6.
  • Gabapentin at doses of 1800 mg to 3600 mg daily can provide good levels of pain relief to some people with postherpetic neuralgia and peripheral diabetic neuropathy 5.

Adverse Effects

  • Common adverse effects of gabapentin include dizziness, somnolence, peripheral edema, and gait disturbance 5, 6.
  • Adverse effects are typically mild to moderate and usually subside within approximately 10 days from the initiation of treatment 6.

References

Guideline

adult cancer pain.

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

Research

Gabapentin dosing in the treatment of epilepsy.

Clinical therapeutics, 2003

Research

Gabapentin for chronic neuropathic pain in adults.

The Cochrane database of systematic reviews, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.